128 related articles for article (PubMed ID: 11073960)
1. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53.
Guerardel C; Deltour S; Pinte S; Monte D; Begue A; Godwin AK; Leprince D
J Biol Chem; 2001 Feb; 276(5):3078-89. PubMed ID: 11073960
[TBL] [Abstract][Full Text] [Related]
2. Identification of a second G-C-rich promoter conserved in the human, murine and rat tumor suppressor genes HIC1.
Pinte S; Guérardel C; Deltour-Balerdi S; Godwin AK; Leprince D
Oncogene; 2004 May; 23(22):4023-31. PubMed ID: 15007385
[TBL] [Abstract][Full Text] [Related]
3. Genomic organization and alternative transcripts of the human Connexin40 gene.
Dupays L; Mazurais D; Rücker-Martin C; Calmels T; Bernot D; Cronier L; Malassiné A; Gros D; Théveniau-Ruissy M
Gene; 2003 Feb; 305(1):79-90. PubMed ID: 12594044
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the human RFC-1 gene encoding a folate transporter reveals multiple promoters and alternatively spliced transcripts with 5' end heterogeneity.
Tolner B; Roy K; Sirotnak FM
Gene; 1998 May; 211(2):331-41. PubMed ID: 9602167
[TBL] [Abstract][Full Text] [Related]
5. The carboxy-terminal end of the candidate tumor suppressor gene HIC-1 is phylogenetically conserved.
Deltour S; Guerardel C; Stehelin D; Leprince D
Biochim Biophys Acta; 1998 Nov; 1443(1-2):230-2. PubMed ID: 9838134
[TBL] [Abstract][Full Text] [Related]
6. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.
Wales MM; Biel MA; el Deiry W; Nelkin BD; Issa JP; Cavenee WK; Kuerbitz SJ; Baylin SB
Nat Med; 1995 Jun; 1(6):570-7. PubMed ID: 7585125
[TBL] [Abstract][Full Text] [Related]
7. Regulation of PAX-6 gene transcription: alternate promoter usage in human brain.
Okladnova O; Syagailo YV; Mössner R; Riederer P; Lesch KP
Brain Res Mol Brain Res; 1998 Oct; 60(2):177-92. PubMed ID: 9757029
[TBL] [Abstract][Full Text] [Related]
8. Putative tumor suppressor protein 4.1B is differentially expressed in kidney and brain via alternative promoters and 5' alternative splicing.
Gascard P; Parra MK; Zhao Z; Calinisan VR; Nunomura W; Rivkees SA; Mohandas N; Conboy JG
Biochim Biophys Acta; 2004 Oct; 1680(2):71-82. PubMed ID: 15488987
[TBL] [Abstract][Full Text] [Related]
9. Alternative 5' exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini.
Parra MK; Gee SL; Koury MJ; Mohandas N; Conboy JG
Blood; 2003 May; 101(10):4164-71. PubMed ID: 12522012
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of multiple isoforms of a murine and human tumor suppressor, patched, having distinct first exons.
Nagao K; Toyoda M; Takeuchi-Inoue K; Fujii K; Yamada M; Miyashita T
Genomics; 2005 Apr; 85(4):462-71. PubMed ID: 15780749
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the human GDNF gene reveals an inducible promoter, three exons, a triplet repeat within the 3'-UTR and alternative splice products.
Grimm L; Holinski-Feder E; Teodoridis J; Scheffer B; Schindelhauer D; Meitinger T; Ueffing M
Hum Mol Genet; 1998 Nov; 7(12):1873-86. PubMed ID: 9811930
[TBL] [Abstract][Full Text] [Related]
12. Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene.
Walsh NC; Cahill M; Carninci P; Kawai J; Okazaki Y; Hayashizaki Y; Hume DA; Cassady AI
Gene; 2003 Mar; 307():111-23. PubMed ID: 12706893
[TBL] [Abstract][Full Text] [Related]
13. Complete structure of the murine p36 (annexin II) gene. Identification of mRNAs for both the murine and the human gene with alternatively spliced 5' noncoding exons.
Fey MF; Moffat GJ; Vik DP; Meisenhelder J; Saris CJ; Hunter T; Tack BF
Biochim Biophys Acta; 1996 May; 1306(2-3):160-70. PubMed ID: 8634333
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
[TBL] [Abstract][Full Text] [Related]
15. Isolation and embryonic expression of the novel mouse gene Hic1, the homologue of HIC1, a candidate gene for the Miller-Dieker syndrome.
Grimm C; Spörle R; Schmid TE; Adler ID; Adamski J; Schughart K; Graw J
Hum Mol Genet; 1999 Apr; 8(4):697-710. PubMed ID: 10072440
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer.
Fujii H; Biel MA; Zhou W; Weitzman SA; Baylin SB; Gabrielson E
Oncogene; 1998 Apr; 16(16):2159-64. PubMed ID: 9572497
[TBL] [Abstract][Full Text] [Related]
17. [Chromosome arm 17p13.3: could HIC1 be the one ?].
Chopin V; Leprince D
Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
[TBL] [Abstract][Full Text] [Related]
18. The genomic structure of two protein kinase CK2alpha genes of Xenopus laevis and features of the putative promoter region.
Wilhelm V; Neckelman G; Allende JE; Allende CC
Mol Cell Biochem; 2001 Nov; 227(1-2):175-83. PubMed ID: 11827169
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel first exons in Ad4BP/SF-1 (NR5A1) gene and their tissue- and species-specific usage.
Kimura R; Yoshii H; Nomura M; Kotomura N; Mukai T; Ishihara S; Ohba K; Yanase T; Gotoh O; Nawata H; Morohashi K
Biochem Biophys Res Commun; 2000 Nov; 278(1):63-71. PubMed ID: 11071856
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.
Deltour S; Pinte S; Guérardel C; Leprince D
Biochem Biophys Res Commun; 2001 Sep; 287(2):427-34. PubMed ID: 11554746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
